A Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Cabazitaxel (Primary) ; Mitoxantrone (Primary) ; Prednisone (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 20 Jul 2017 Status changed from active, no longer recruiting to completed.
- 24 Oct 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.
- 01 Feb 2014 Interim results presented at the 2014 Genitourinary Cancers Symposium.